They were reported to exhibit their efficacy through upregulating miR-215-5p expression and suppressing SREBP1 expression in breast cancer cells (MCF-7 and MDA-MB-231) and in xenograft mouse models [123]. This evidence concerns the gene SREBF1 and breast carcinoma.